GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
217
c/glp1science·posted 2 months ago by u/formulary_fighter

[PSA] receptor is not what most of this community thinks it is

Question

receptor is not what most of this community thinks it is — with the reasoning, because a rule without a reason gets ignored.

The GIP question, which is the most interesting unsettled thing in this field.

Dual agonism at GIP and GLP-1 receptors produces clinical results that are robust and well replicated. What is not settled is the mechanism by which the GIP arm contributes — there is a genuine scientific argument about agonism versus antagonism at that receptor, with reasonable people and real data on both sides.

It is worth sitting with that. The clinical effect is not in doubt; the explanation is. That is an ordinary state of affairs in pharmacology and it is a good corrective to the confident mechanistic stories that circulate here.

Asked a question here that I thought was stupid and got three papers back. Best thread I have been in on this site.

The mental model, in four steps, that makes the rest of this site legible.

One: gut hormones amplify the insulin response to food. Two: agonists at those receptors act peripherally on insulin secretion and gastric emptying, and centrally on appetite. Three: structural modification gives them a long half-life, so exposure is smooth and weekly. Four: tolerance develops to some effects and not to others.

From those four, most of what the experience boards report falls out: why the side effects cluster early, why they settle at a stable dose, why appetite reduction persists, and why the scale and the appetite move on different clocks.

If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.

1,829 up / 1,612 down53% upvoted16 commentsid ys002c29 May 2026

16 comments

7 in this archive, depth 4

best — the order this archive was captured in

u/noor_hovland22 points·2 months ago

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

replysharereportpermalink
u/gustav_vermeulen20 points·2 months ago

Started reading limitations sections first. It has changed how much weight I give to almost everything posted here.

replysharereportpermalink
u/incretin_ivyMOD11 points·2 months ago

Retitled to distinguish preclinical from clinical, which the original ran together.

replysharereportpermalink
u/formulary_fighterOPappeals-17 points·2 months ago

gastric emptying slows, it does not stop

replysharereportpermalink
u/emeka_chowdhury1 point·2 months ago

gastric emptying slows, it does not stop

formulary_fighter is right that mechanism gives direction and not magnitude. Worth pinning.

replysharereportpermalink
u/sanne_delgado1 point·2 months ago

mechanism explains a direction, not a magnitude

replysharereportpermalink
u/rafael_ostergaard10 points·2 months ago

Started reading limitations sections first.

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.